Onderzoeksgrade Emfizatamab

GNC038, GNC-038, GNC038, CAS:2559704-23-1

Mammalian Cells

CD19, DifferentiationantigenCD19, T-cellsurfaceantigenLeu-12, B-lymphocyteantigenCD19, B-lymphocytesurfaceantigenB4, B7-H1, Programmedcelldeath1ligand1, PDCD1ligand1, PDCD1L1, B7homolog1, PDCD1LG1, PDL1, hPD-L1, Programmeddeathligand1, B7H1, PD-L1, CD274, T3E, T-cellsurfaceantigenT3/Leu-4epsilonchain, CD3e, CD3E, T-cellsurfaceglycoproteinCD3epsilonchain, Tumornecrosisfactorreceptorsuperfamilymember9, CD137,4-1BBligandreceptor, CDw137, TNFRSF9, T-cellantigenILA, T-cellantigen4-1BBhomolog, ILA

ELISA, Bioactivity: FACS, Functional assay, Research in vivo

Protein A/G purified from cell culture supernatant.

1mg/ml

Please contact with the lab for this information.

>95% as determined by SDS-PAGE.

Liquid

0.01M PBS, pH7.4.

Use a manual defrost freezer and avoid repeated freeze-thaw cycles. Store at4°C short term (1-2weeks) . Store at-20°C 12 months. Store at -891°C long term.

For research use only. Not suitable for clinical or therapeutic use.

0.01M PBS, pH7.4.

Human

(scFv-kappa-heavy) -G1_L-kappa- (scFv-heavy-kappa) - (scFv-heavy-kappa)